Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|September 30, 2024

Pharma Pulse 9/30/24: The Secret Sauce for Top School Graduates, Cigna’s 2024 Vitality Report & more

The latest news for pharma industry insiders.

What is the Secret Sauce for Top School Graduates to Convert Start-Up Ideas into Sustainable Firms?

Martin Gonzalez is a Principal of Org and Leadership Development at Google. Previously, he was a management consultant with the Boston Consulting Group and a product manager with Johnson & Johnson. Gonzalez is co-author of The Bonfire Moment, one of Thinkers50 10 Best New Management Books for 2024.

Cigna’s 2024 Vitality Report Shows First Improvements Since 2022

Young Americans are reporting a 2% increase in “high vitality,” with “high vitality” rates now at 20% overall, according to the results of Cigna’s third annual Vitality in America report.

‘We Are Not a Normal Company’: OpenAI’s Latest Drama

More high-level departures caught some at the high-flying A.I. start-up off guard, as the company seeks to raise billions to fund its operations and ambitious goals.

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

Next Health, the world's most advanced brand of proactive healthcare centers, is bringing two health optimization and longevity centers to Tampa and St. Petersburg through an area development agreement. This announcement follows Next Health’s 11-unit expansion in the Sunshine State across the cities of Miami, Ft. Lauderdale, Palm Beach, and Boca Raton.

IMPACT SUPPLY CHAIN PARTNERS on LinkedIn

It was great to see our colleague, Kaushik Datta providing insights on the incredibly important topic of the Pharma Industry's work to minimize environmental impact and achieve their sustainability goals.

#Sustainability
#ImpactSupplyChainPartners

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.